vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and Perion Network Ltd. (PERI). Click either name above to swap in a different company.

Perion Network Ltd. is the larger business by last-quarter revenue ($368.7M vs $37.2M, roughly 9.9× Organogenesis Holdings Inc.). Over the past eight quarters, Perion Network Ltd.'s revenue compounded faster (16.4% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Perion Network Ltd. is a publicly traded advertising technology company that provides digital advertising technology solutions to advertisers, agencies, retailers, and publishers. Its core offerings are delivered through Perion One, a unified omnichannel advertising platform designed to support campaign planning, activation, optimisation, and measurement across channels and verticals including connected television (CTV), digital out-of-home (DOOH), display, video advertising, as well as retai...

ORGO vs PERI — Head-to-Head

Bigger by revenue
PERI
PERI
9.9× larger
PERI
$368.7M
$37.2M
ORGO
Faster 2-yr revenue CAGR
PERI
PERI
Annualised
PERI
16.4%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ORGO
ORGO
PERI
PERI
Revenue
$37.2M
$368.7M
Net Profit
$7.7M
Gross Margin
30.8%
Operating Margin
-185.1%
2.0%
Net Margin
2.1%
Revenue YoY
-57.1%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
PERI
PERI
Q1 26
$37.2M
Q4 25
$225.6M
Q3 25
$150.9M
$368.7M
Q2 25
$101.0M
$266.5M
Q1 25
$86.7M
$157.8M
Q4 24
$126.7M
Q3 24
$115.2M
$508.9M
Q2 24
$130.2M
$323.6M
Net Profit
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
$43.7M
Q3 25
$21.6M
$7.7M
Q2 25
$-9.4M
$5.6M
Q1 25
$-18.8M
$11.8M
Q4 24
$7.7M
Q3 24
$12.3M
$78.0M
Q2 24
$-17.0M
$45.2M
Gross Margin
ORGO
ORGO
PERI
PERI
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ORGO
ORGO
PERI
PERI
Q1 26
-185.1%
Q4 25
28.1%
Q3 25
13.7%
2.0%
Q2 25
-12.5%
-1.7%
Q1 25
-30.9%
5.4%
Q4 24
8.1%
Q3 24
5.4%
15.1%
Q2 24
-10.7%
13.7%
Net Margin
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
19.4%
Q3 25
14.3%
2.1%
Q2 25
-9.3%
2.1%
Q1 25
-21.7%
7.5%
Q4 24
6.1%
Q3 24
10.7%
15.3%
Q2 24
-13.1%
14.0%
EPS (diluted)
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$-0.10
Q1 25
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
PERI
PERI
Cash + ST InvestmentsLiquidity on hand
$91.4M
$156.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$722.9M
Total Assets
$520.0M
$915.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
PERI
PERI
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
$156.2M
Q2 25
$73.1M
$156.2M
Q1 25
$110.0M
$156.2M
Q4 24
$135.6M
Q3 24
$94.3M
$187.6M
Q2 24
$89.9M
$187.6M
Total Debt
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
$300.1M
Q3 25
$255.1M
$722.9M
Q2 25
$233.2M
$722.9M
Q1 25
$242.9M
$722.9M
Q4 24
$262.9M
Q3 24
$278.5M
$718.1M
Q2 24
$263.5M
$718.1M
Total Assets
ORGO
ORGO
PERI
PERI
Q1 26
$520.0M
Q4 25
$598.7M
Q3 25
$509.8M
$915.5M
Q2 25
$461.1M
$915.5M
Q1 25
$467.4M
$915.5M
Q4 24
$497.9M
Q3 24
$446.3M
$1.1B
Q2 24
$443.2M
$1.1B
Debt / Equity
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
PERI
PERI
Operating Cash FlowLast quarter
$2.6M
Free Cash FlowOCF − Capex
$-2.9M
FCF MarginFCF / Revenue
-0.8%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
0.34×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
$39.4M
Q3 25
$3.1M
$2.6M
Q2 25
$-32.9M
Q1 25
$-19.9M
Q4 24
$10.9M
Q3 24
$8.7M
$105.2M
Q2 24
$4.7M
Free Cash Flow
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
$-2.9M
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
$104.7M
Q2 24
$2.9M
FCF Margin
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
15.4%
Q3 25
0.6%
-0.8%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
20.6%
Q2 24
2.2%
Capex Intensity
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
2.1%
Q3 25
1.5%
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
0.1%
Q2 24
1.4%
Cash Conversion
ORGO
ORGO
PERI
PERI
Q1 26
Q4 25
0.90×
Q3 25
0.14×
0.34×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
1.35×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORGO
ORGO

Segment breakdown not available.

PERI
PERI

Advertising Solutions$231.4M63%
Search Advertising$137.3M37%

Related Comparisons